Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome

Lawrence M. Title, Evan Lonn, Francois Charbonneau, Marinda Fung, Kieren Mather, Subodh Verma, Todd J. Anderson

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Metabolic syndrome (MetSyn) may predispose to cardiovascular disease (CVD) by causing vascular dysfunction. This study aimed to determine the association of MetSyn with vascular function, as assessed by brachial artery flow-mediated dilatation (FMD) and hyperemic shear stress (HSS). A total of 1,417 male firefighters without established diabetes and CVD were classified for MetSyn, according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP) definition. MetSyn was present in 267 individuals (19%). Although FMD was lower in those with versus without MetSyn (8.1 ± 4.1 vs 8.7 ± 4.0%; p = 0.02), this was not significant after adjusting for baseline differences (age, smoking, and brachial artery diameter) (p = 0.2). However, HSS was significantly lower in those with versus without MetSyn (72.0 ± 27.8 vs 80.9 ± 24.8 dyne/cm2; p < 0.001), and there was a significant inverse graded relationship with the number of NCEP criteria present (mean HSS for those with 0, 1, 2, 3, 4, and 5 criteria: 83.2 ± 22.5, 82.2 ± 24.7, 76.5 ± 27.2, 74.3 ± 27.4, 66.5 ± 28.4, 67.1 ± 27.6 dyne/cm2; p < 0.001 for trend). The individual NCEP criteria of abdominal obesity, systolic hypertension, and impaired fasting glucose were independent predictors for HSS. In conclusion, MetSyn was not associated with impaired FMD. Alternatively, HSS, a measure of microvascular function, was significantly lower in those with MetSyn. Thus, MetSyn may contribute to CVD by causing microvascular dysfunction.

Original languageEnglish
Pages (from-to)263-270
Number of pages8
JournalVascular Medicine
Volume13
Issue number4
DOIs
StatePublished - Nov 2008

Fingerprint

Brachial Artery
Dilatation
Cardiovascular Diseases
Blood Vessels
Firefighters
Abdominal Obesity
Fasting
Smoking
Cholesterol
Hypertension
Education
Glucose

Keywords

  • Endothelium
  • Insulin resistance
  • Metabolic syndrome
  • Obesity
  • Vasodilation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome. / Title, Lawrence M.; Lonn, Evan; Charbonneau, Francois; Fung, Marinda; Mather, Kieren; Verma, Subodh; Anderson, Todd J.

In: Vascular Medicine, Vol. 13, No. 4, 11.2008, p. 263-270.

Research output: Contribution to journalArticle

Title, Lawrence M. ; Lonn, Evan ; Charbonneau, Francois ; Fung, Marinda ; Mather, Kieren ; Verma, Subodh ; Anderson, Todd J. / Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome. In: Vascular Medicine. 2008 ; Vol. 13, No. 4. pp. 263-270.
@article{1d2a0599a4e048b3bd1c4efbae5fd924,
title = "Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome",
abstract = "Metabolic syndrome (MetSyn) may predispose to cardiovascular disease (CVD) by causing vascular dysfunction. This study aimed to determine the association of MetSyn with vascular function, as assessed by brachial artery flow-mediated dilatation (FMD) and hyperemic shear stress (HSS). A total of 1,417 male firefighters without established diabetes and CVD were classified for MetSyn, according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP) definition. MetSyn was present in 267 individuals (19{\%}). Although FMD was lower in those with versus without MetSyn (8.1 ± 4.1 vs 8.7 ± 4.0{\%}; p = 0.02), this was not significant after adjusting for baseline differences (age, smoking, and brachial artery diameter) (p = 0.2). However, HSS was significantly lower in those with versus without MetSyn (72.0 ± 27.8 vs 80.9 ± 24.8 dyne/cm2; p < 0.001), and there was a significant inverse graded relationship with the number of NCEP criteria present (mean HSS for those with 0, 1, 2, 3, 4, and 5 criteria: 83.2 ± 22.5, 82.2 ± 24.7, 76.5 ± 27.2, 74.3 ± 27.4, 66.5 ± 28.4, 67.1 ± 27.6 dyne/cm2; p < 0.001 for trend). The individual NCEP criteria of abdominal obesity, systolic hypertension, and impaired fasting glucose were independent predictors for HSS. In conclusion, MetSyn was not associated with impaired FMD. Alternatively, HSS, a measure of microvascular function, was significantly lower in those with MetSyn. Thus, MetSyn may contribute to CVD by causing microvascular dysfunction.",
keywords = "Endothelium, Insulin resistance, Metabolic syndrome, Obesity, Vasodilation",
author = "Title, {Lawrence M.} and Evan Lonn and Francois Charbonneau and Marinda Fung and Kieren Mather and Subodh Verma and Anderson, {Todd J.}",
year = "2008",
month = "11",
doi = "10.1177/1358863X08095154",
language = "English",
volume = "13",
pages = "263--270",
journal = "Vascular Medicine",
issn = "1358-863X",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome

AU - Title, Lawrence M.

AU - Lonn, Evan

AU - Charbonneau, Francois

AU - Fung, Marinda

AU - Mather, Kieren

AU - Verma, Subodh

AU - Anderson, Todd J.

PY - 2008/11

Y1 - 2008/11

N2 - Metabolic syndrome (MetSyn) may predispose to cardiovascular disease (CVD) by causing vascular dysfunction. This study aimed to determine the association of MetSyn with vascular function, as assessed by brachial artery flow-mediated dilatation (FMD) and hyperemic shear stress (HSS). A total of 1,417 male firefighters without established diabetes and CVD were classified for MetSyn, according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP) definition. MetSyn was present in 267 individuals (19%). Although FMD was lower in those with versus without MetSyn (8.1 ± 4.1 vs 8.7 ± 4.0%; p = 0.02), this was not significant after adjusting for baseline differences (age, smoking, and brachial artery diameter) (p = 0.2). However, HSS was significantly lower in those with versus without MetSyn (72.0 ± 27.8 vs 80.9 ± 24.8 dyne/cm2; p < 0.001), and there was a significant inverse graded relationship with the number of NCEP criteria present (mean HSS for those with 0, 1, 2, 3, 4, and 5 criteria: 83.2 ± 22.5, 82.2 ± 24.7, 76.5 ± 27.2, 74.3 ± 27.4, 66.5 ± 28.4, 67.1 ± 27.6 dyne/cm2; p < 0.001 for trend). The individual NCEP criteria of abdominal obesity, systolic hypertension, and impaired fasting glucose were independent predictors for HSS. In conclusion, MetSyn was not associated with impaired FMD. Alternatively, HSS, a measure of microvascular function, was significantly lower in those with MetSyn. Thus, MetSyn may contribute to CVD by causing microvascular dysfunction.

AB - Metabolic syndrome (MetSyn) may predispose to cardiovascular disease (CVD) by causing vascular dysfunction. This study aimed to determine the association of MetSyn with vascular function, as assessed by brachial artery flow-mediated dilatation (FMD) and hyperemic shear stress (HSS). A total of 1,417 male firefighters without established diabetes and CVD were classified for MetSyn, according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP) definition. MetSyn was present in 267 individuals (19%). Although FMD was lower in those with versus without MetSyn (8.1 ± 4.1 vs 8.7 ± 4.0%; p = 0.02), this was not significant after adjusting for baseline differences (age, smoking, and brachial artery diameter) (p = 0.2). However, HSS was significantly lower in those with versus without MetSyn (72.0 ± 27.8 vs 80.9 ± 24.8 dyne/cm2; p < 0.001), and there was a significant inverse graded relationship with the number of NCEP criteria present (mean HSS for those with 0, 1, 2, 3, 4, and 5 criteria: 83.2 ± 22.5, 82.2 ± 24.7, 76.5 ± 27.2, 74.3 ± 27.4, 66.5 ± 28.4, 67.1 ± 27.6 dyne/cm2; p < 0.001 for trend). The individual NCEP criteria of abdominal obesity, systolic hypertension, and impaired fasting glucose were independent predictors for HSS. In conclusion, MetSyn was not associated with impaired FMD. Alternatively, HSS, a measure of microvascular function, was significantly lower in those with MetSyn. Thus, MetSyn may contribute to CVD by causing microvascular dysfunction.

KW - Endothelium

KW - Insulin resistance

KW - Metabolic syndrome

KW - Obesity

KW - Vasodilation

UR - http://www.scopus.com/inward/record.url?scp=58249093038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58249093038&partnerID=8YFLogxK

U2 - 10.1177/1358863X08095154

DO - 10.1177/1358863X08095154

M3 - Article

C2 - 18940902

AN - SCOPUS:58249093038

VL - 13

SP - 263

EP - 270

JO - Vascular Medicine

JF - Vascular Medicine

SN - 1358-863X

IS - 4

ER -